Cargando…

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer

Heterogeneous nuclear ribonucleoprotein K (hnRNPK) transcripts are abundant in estrogen receptor (ER)- or progesterone receptor (PR)-positive breast cancer. However, the biological functions of hnRNPK in the ER-mediated signaling pathway have remained largely unknown. Therefore, this study analyzes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwabuchi, Erina, Miki, Yasuhiro, Suzuki, Takashi, Hirakawa, Hisashi, Ishida, Takanori, Sasano, Hironobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962001/ https://www.ncbi.nlm.nih.gov/pubmed/33806648 http://dx.doi.org/10.3390/ijms22052581

Ejemplares similares

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

ODP562 ZnT5 Involvement in EMT in Breast Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2022)

Visualization of the protein–protein interactions of hormone receptors in hormone-dependent cancer research
por: Iwabuchi, Erina, et al.
Publicado: (2022)

In Situ Evaluation of Estrogen Receptor Dimers in Breast Carcinoma Cells: Visualization of Protein-Protein Interactions
por: Iwabuchi, Erina, et al.
Publicado: (2017)

ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
por: Miki, Yasuhiro, et al.
Publicado: (2022)

The Visualization of Protein-Protein Interactions in Breast Cancer: Deployment Study in Pathological Examination
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma
por: Masuda, Mariko, et al.
Publicado: (2012)

ODP543 Chemotherapy-induced extracellular HSP70 enhances pro-tumorigenic effects of macrophages in breast cancers.
por: Yamaguchi, Mio, et al.
Publicado: (2022)

Exploring Protein–Protein Interaction in the Study of Hormone-Dependent Cancers
por: Miki, Yasuhiro, et al.
Publicado: (2018)

Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells
por: Shishkin, Sergey S., et al.
Publicado: (2019)

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma
por: Mayama, Akifumi, et al.
Publicado: (2018)

OR22-05 Progesterone Receptor-Grb2 Interaction Is Associated With Better Outcomes In Breast Cancer
por: Wittayavimol, Nattamolphan, et al.
Publicado: (2023)

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens
por: Takagi, Kiyoshi, et al.
Publicado: (2018)

Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment
por: Sakurai, Minako, et al.
Publicado: (2017)

Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B
por: He, Yaowu, et al.
Publicado: (2008)

Small nuclear ribonucleoproteins and heterogeneous nuclear ribonucleoproteins in the amphibian germinal vesicle: loops, spheres, and snurposomes
Publicado: (1991)

Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma
por: Roychoudhury, P, et al.
Publicado: (2007)

Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases
por: Low, Yi-Hua, et al.
Publicado: (2020)

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor
por: Takagi, Kiyoshi, et al.
Publicado: (2014)

Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast
por: Yoda, Tomomi, et al.
Publicado: (2014)

Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
por: Sudhakaran, Meenakshi, et al.
Publicado: (2023)

Reply: Evidence for heterogeneous nuclear ribonucleoprotein k over expression in oral squamous cell carcinoma
por: Carpenter, B, et al.
Publicado: (2007)

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
por: Barboro, P, et al.
Publicado: (2009)

Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
por: Chen, Xu, et al.
Publicado: (2016)

Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis
por: Aboushousha, Tarek, et al.
Publicado: (2018)

Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53‐dependent signaling pathway
por: Li, Mengyuan, et al.
Publicado: (2022)

Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor
por: Ebata, Akiko, et al.
Publicado: (2023)

Functions of Heterogeneous Nuclear Ribonucleoproteins in Stem Cell Potency and Differentiation
por: Chen, Qishan, et al.
Publicado: (2013)

Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma
por: Liu, Hongfei, et al.
Publicado: (2020)

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer
por: Carpenter, B, et al.
Publicado: (2006)

Heterogeneous Nuclear Ribonucleoprotein K Interacts with Abi-1 at Postsynaptic Sites and Modulates Dendritic Spine Morphology
por: Proepper, Christian, et al.
Publicado: (2011)

Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma
por: Chung, I-Che, et al.
Publicado: (2014)

ODP559 The prognostic role of IL-17A-neutrophils crosstalk in triple-negative breast cancer
por: Khalid, Freeha, et al.
Publicado: (2022)

Abnormal expression of miR‐1 in breast carcinoma as a potent prognostic factor
por: Minemura, Hiroyuki, et al.
Publicado: (2015)

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance
por: Minemura, Hiroyuki, et al.
Publicado: (2016)

Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing
por: Ji, Yingbiao, et al.
Publicado: (2009)

Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex
por: Sapir, Tamar, et al.
Publicado: (2022)

Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis
por: Guo, Yantong, et al.
Publicado: (2012)

Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells
por: Otoshi, Taiyo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ume5eiodpeef7116rtgocf8lno